Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322528 (5-[3-[4-(3-thienyl)-1H-imidazol-2-yl]chroman-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322529 (5-[3-[4-(2-thienyl)-1H-imidazol-2-yl]chroman-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.600 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322528 (5-[3-[4-(3-thienyl)-1H-imidazol-2-yl]chroman-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322529 (5-[3-[4-(2-thienyl)-1H-imidazol-2-yl]chroman-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322530 (5-[3-[5-(2-chlorophenyl)-1H-imidazol-2-yl]chroman-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322530 (5-[3-[5-(2-chlorophenyl)-1H-imidazol-2-yl]chroman-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322531 (5-[3-[5-(3-chlorophenyl)-1H-imidazol-2-yl]chroman-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322532 (5-[3-[4-(benzofuran-3-yl)-1H-imidazol-2-yl]chroman...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322533 (5-[3-[5-(3-pyridyl)-1H-imidazol-2-yl]chroman-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322533 (5-[3-[5-(3-pyridyl)-1H-imidazol-2-yl]chroman-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322535 (5-[3-[5-(4-fluorophenyl)-1H-imidazol-2-yl]chroman-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322536 (5-[3-[5-(1,3-benzodioxol-5-yl)-1H-imidazol-2-yl]ch...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322536 (5-[3-[5-(1,3-benzodioxol-5-yl)-1H-imidazol-2-yl]ch...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322537 (5-[3-[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-1H-imid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322540 (5-[3-(5-phenyl-1H-pyrazol-3-yl)chroman-6-yl]oxy-3,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322540 (5-[3-(5-phenyl-1H-pyrazol-3-yl)chroman-6-yl]oxy-3,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322541 (5-[[(3S)-3-(4-phenyl-1H-imidazol-2-yl)-2,3-dihydro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322542 (5-[[(3R)-3-(4-phenyl-1H-imidazol-2-yl)-2,3-dihydro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322542 (5-[[(3R)-3-(4-phenyl-1H-imidazol-2-yl)-2,3-dihydro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322529 (5-[3-[4-(2-thienyl)-1H-imidazol-2-yl]chroman-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322528 (5-[3-[4-(3-thienyl)-1H-imidazol-2-yl]chroman-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322528 (5-[3-[4-(3-thienyl)-1H-imidazol-2-yl]chroman-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322527 (5-[3-(4-tert-butyl-1H-imidazol-2-yl)chroman-6-yl]o...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322525 (5-[3[4-(4-pyridyl)-1H-imidazol-2-yl]chroman-6-yl]o...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322518 (5-[3-(1H-benzimidazol-2-yl)chroman-6-yl]oxy-3,4-di...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322518 (5-[3-(1H-benzimidazol-2-yl)chroman-6-yl]oxy-3,4-di...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322541 (5-[[(3S)-3-(4-phenyl-1H-imidazol-2-yl)-2,3-dihydro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322538 (5-[[3-(4-phenyl-1H-imidazol-2-yl)-2H-chromen-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322535 (5-[3-[5-(4-fluorophenyl)-1H-imidazol-2-yl]chroman-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322532 (5-[3-[4-(benzofuran-3-yl)-1H-imidazol-2-yl]chroman...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322529 (5-[3-[4-(2-thienyl)-1H-imidazol-2-yl]chroman-6-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322525 (5-[3[4-(4-pyridyl)-1H-imidazol-2-yl]chroman-6-yl]o...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322531 (5-[3-[5-(3-chlorophenyl)-1H-imidazol-2-yl]chroman-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322521 (5-[3-(4-phenyl-1H-imidazol-2-yl)chroman-6-yl]oxy-3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <4 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322527 (5-[3-(4-tert-butyl-1H-imidazol-2-yl)chroman-6-yl]o...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322539 (5-[3-(3-phenyl-1,2,4-oxadiazol-5-yl)chroman-6-yl]o...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase B-raf [416-766,V600E] (Homo sapiens (Human)) | BDBM322519 (5-[3-(7-chloro-1H-benzimidazol-2-yl]chroman-6-yl]o...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description To determine whether compounds bind to RAF kinases, they are tested in a competition binding assay. The Invitrogen LanthaScreen Eu binding assay invo... | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322519 (5-[3-(7-chloro-1H-benzimidazol-2-yl]chroman-6-yl]o...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
RAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D] (Homo sapiens (Human)) | BDBM322534 (5-[3-[5-(4-methylsulfonylphenyl)-1H-imidazol-2-yl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | US Patent US10183939 (2019) BindingDB Entry DOI: 10.7270/Q2QN68WX | ||||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 56 total ) | Next | Last >> |